Cargando…
Different maturation cocktails provide dendritic cells with different chemoattractive properties
BACKGROUND: Dendritic cells (DC) are currently implemented as immunotherapeutic strategy for the treatment of tumor patients based on their central role in the immune system. Despite good results were obtained in vitro and in animal models, their clinical use has provided limited success suggesting...
Autores principales: | Massa, Chiara, Thomas, Carolin, Wang, Ena, Marincola, Francesco, Seliger, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467838/ https://www.ncbi.nlm.nih.gov/pubmed/26695182 http://dx.doi.org/10.1186/s12967-015-0528-7 |
Ejemplares similares
-
Molecular signatures of maturing dendritic cells: implications for testing the quality of dendritic cell therapies
por: Jin, Ping, et al.
Publicado: (2010) -
Enhanced function of vaccine dendritic cells from obese donors upon inhibition of the lipid metabolism
por: Massa, Chiara, et al.
Publicado: (2022) -
The Dark Side of Dendritic Cells: Development and Exploitation of Tolerogenic Activity That Favor Tumor Outgrowth and Immune Escape
por: Seliger, Barbara, et al.
Publicado: (2013) -
Transcriptional profiling of dendritic cells matured in different osmolarities
por: Chessa, Federica, et al.
Publicado: (2015) -
An optimized cocktail of small molecule inhibitors promotes the maturation of dendritic cells in GM-CSF mouse bone marrow culture
por: Matsuba, Shintaro, et al.
Publicado: (2023)